Leukocyte removal therapy for ulcerative colitis does not affect postoperative complications.

作者信息

Ikeuchi Hiroki, Yamamura Takehira, Kusunoki Masato, Nakano Hiroki, Uchino Motoi, Nakamura Mitsuhiro, Noda Masafumi, Yanagi Hidenori, Matsumoto Takayuki

机构信息

Second Department of Surgery, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, Japan.

出版信息

J Gastroenterol. 2006 Sep;41(9):848-54. doi: 10.1007/s00535-006-1875-1.

DOI:10.1007/s00535-006-1875-1

PMID:17048048

Abstract

BACKGROUND

We investigated the incidence of postoperative complications in patients treated with or without preoperative leukocyte removal therapy (LRT).

METHODS

The case notes of 387 patients with ulcerative colitis (UC) who underwent surgical intervention were retrospectively reviewed. One hundred nine patients were treated with LRT within 8 weeks before surgery (LRT group), and 278 had not received LRT since at least 8 weeks before surgery (without LRT group). We reviewed the postoperative complications according to type of initial operation.

RESULTS

Of the patients who underwent an ileal J-pouch anal anastomosis (IPAA) without an ileostomy, 3 (6.5%) in the LRT group developed pouch-related complications (PRC), while 11 (7.5%) in the without LRT group developed PRC. The overall postoperative complication rates were 28.3% in the LRT group and 21.8% in the without LRT group. For patients who underwent an IPAA with an ileostomy, the overall rates of postoperative complications were 39.1% in the LRT group and 31.8% in the without LRT group. Among those undergoing a total colectomy, 33.3% in the LRT group and 18.2% in the without LRT group had postoperative complications. No statistically significant differences were demonstrated between the two groups with respect to postoperative complications.